EW
Edwards Lifesciences Corporation
NYQ
$85.88
-1.78
(-2.03%)
Neutral · +0.60σ
Grade C
Valuation
Market cap
$49.4B
P/E (ttm)
46.4
Forward P/E
25.5
Beta (5y)
0.87
Shares out
575.8M
Div yield
—
Profitability & returns
ROE
10.5%
Net margin
17.4%
FCF margin
14.3%
Debt / equity
0.07
Trading information
Last price
$85.88
Day range
$85.88 – $85.88
52-wk range
$74.66 – $89.14
Avg volume
5.1M
RSI (2)
20.4
TAO zone
Neutral
Company
Sector
Healthcare
Industry
Medical Devices
Exchange
NYQ
Next earnings
2026-07-23
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricu…